Inga, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 10.998
AS - Asia 3.239
EU - Europa 2.318
SA - Sud America 577
AF - Africa 73
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 8
Totale 17.226
Nazione #
US - Stati Uniti d'America 10.888
SG - Singapore 1.389
VN - Vietnam 706
CN - Cina 561
BR - Brasile 475
RU - Federazione Russa 441
IT - Italia 331
SE - Svezia 246
FI - Finlandia 217
GB - Regno Unito 203
UA - Ucraina 191
DE - Germania 188
FR - Francia 148
LV - Lettonia 116
KR - Corea 89
IN - India 87
HK - Hong Kong 83
CA - Canada 66
ID - Indonesia 51
BG - Bulgaria 47
BD - Bangladesh 41
AR - Argentina 39
JO - Giordania 39
JP - Giappone 38
TR - Turchia 36
IQ - Iraq 33
NL - Olanda 32
MX - Messico 30
PL - Polonia 29
AT - Austria 26
ES - Italia 25
ZA - Sudafrica 22
CZ - Repubblica Ceca 19
EC - Ecuador 15
MA - Marocco 15
CO - Colombia 14
CL - Cile 12
GR - Grecia 12
PK - Pakistan 12
PH - Filippine 11
UZ - Uzbekistan 11
AU - Australia 9
IE - Irlanda 9
LT - Lituania 9
DZ - Algeria 8
VE - Venezuela 7
AL - Albania 6
BE - Belgio 6
KE - Kenya 6
NP - Nepal 6
AO - Angola 5
IL - Israele 5
PE - Perù 5
SA - Arabia Saudita 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EG - Egitto 4
ET - Etiopia 4
JM - Giamaica 4
KZ - Kazakistan 4
LK - Sri Lanka 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
OM - Oman 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
EU - Europa 2
GA - Gabon 2
KG - Kirghizistan 2
LI - Liechtenstein 2
LU - Lussemburgo 2
NG - Nigeria 2
NO - Norvegia 2
QA - Qatar 2
SR - Suriname 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KW - Kuwait 1
LB - Libano 1
Totale 17.220
Città #
Fairfield 1.386
Ashburn 1.193
Chandler 916
Singapore 876
Woodbridge 607
Seattle 599
Houston 516
Wilmington 457
San Jose 456
Cambridge 453
Jacksonville 453
Dallas 407
Ann Arbor 276
Santa Clara 254
Columbus 230
Ho Chi Minh City 179
Moscow 179
Hanoi 173
Princeton 171
San Mateo 159
New York 154
Council Bluffs 128
The Dalles 128
Los Angeles 127
Beijing 121
Helsinki 120
Riga 116
Lauterbourg 98
Trento 88
Seoul 84
San Diego 77
Hong Kong 70
Munich 68
Boardman 66
São Paulo 62
London 58
Dong Ket 55
Chicago 50
Dearborn 50
Orem 46
San Paolo di Civitate 45
Da Nang 44
Sofia 44
Jakarta 41
Buffalo 39
Lawrence 39
Phoenix 39
Fremont 38
Falls Church 35
Montreal 33
Tokyo 31
Nuremberg 29
Haiphong 27
Washington 27
Como 26
Warsaw 26
Denver 23
Hefei 22
North Bergen 22
Atlanta 19
Rome 19
Des Moines 18
Redondo Beach 18
Bremen 17
Chennai 17
Izmir 17
Belo Horizonte 16
Brno 16
Frankfurt am Main 16
Toronto 16
Shanghai 15
Stockholm 15
Turku 15
Brooklyn 14
Falkenstein 14
Johannesburg 14
Norwalk 14
Rio de Janeiro 14
Mountain View 13
Poplar 13
Riva Del Garda 13
Genoa 12
Guangzhou 12
Vienna 12
Baghdad 11
Hải Dương 11
Amsterdam 10
Corinth 10
Elk Grove Village 10
Mumbai 10
Paris 10
Salt Lake City 10
Biên Hòa 9
Brasília 9
Tashkent 9
Ankara 8
Fuzhou 8
Kilburn 8
Lappeenranta 8
Manchester 8
Totale 12.864
Nome #
Inherited determinants of early recurrent somatic mutations in prostate cancer 330
Human transcription factors in yeast: the fruitful examples of P53 and NF-кB 312
Conserved Pseudoknots in lncRNA MEG3 Are Essential for Stimulation of the p53 Pathway 312
A highly specific SpCas9 variant is identified by in vivo screening in yeast 304
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma 266
Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas 265
The ribonucleic complex HuR-MALAT1 represses CD133 expression and suppresses epithelial-mesenchymal transition in breast cancer 264
RiboAbacus: a model trained on polyribosome images predicts ribosome density and translational efficiency from mammalian transcriptomes 234
Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer development 229
Whole-genome cartography of p53 response elements ranked on transactivation potential 227
Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity 217
A Cross-Platform Comparison of Affymetrix and Agilent Microarrays Reveals Discordant miRNA Expression in Lung Tumors of c-Raf Transgenic Mice 212
c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma. 211
Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells 208
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 204
Quantitative Analysis of NF-κB Transactivation Specificity Using a Yeast-Based Functional Assay 204
Evolution of p53 transactivation specificity through the lens of a yeast-based functional assay 204
A functional genetic study identifies HAND1 mutations in septation defects of the human heart. 202
Functional analysis of CDKN2A/p16INK4a 5 ' UTR variants predisposing to melanoma 200
Synthesis of 2,6-diamino-substituted purine derivatives and evaluation of cell cycle arrest in breast and colorectal cancer cells 200
A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts. 199
DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties 199
LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β 195
Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code. 194
Yeast as a chassis for developing functional assays to study human P53 190
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding 187
Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach. 186
P53 Family Members Modulate the Expression of PRODH, but Not PRODH2, via Intronic p53 Response Elements. 186
Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer 184
Translation control can shape TP53-dependent cell fate 181
Apigenin rich-Limonium duriusculum (de Girard) Kuntze promotes apoptosis in HCT116 cancer cells 179
The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis. 176
Contribution of yeast and plant research for improving human health. 173
3-Methyl-3-deazaadenine, a stable isostere of N3-methyl-adenine, is efficiently bypassed by replication in vivo and by transcription in vitro. 172
Changing the p53 master regulatory network: ELEMENTary, my dear Mr Watson. 171
Characterization of the p53 mutants ability to inhibit p73β transactivation using a yeast-based functional assay 171
p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening system 170
A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1. 168
Regulatory Crosstalk of Doxorubicin, Estradiol and TNFα Combined Treatment in Breast Cancer-derived Cell Lines 168
The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound. 164
Cooperative interactions between p53 and NFκB enhance cell plasticity. 164
In-silico identification and functional validation of allele-dependent AR enhancers 164
EEC- and ADULT-associated TP63 mutations exhibit functional heterogeneity toward P63 responsive sequences. 161
p53-directed translational control can shape and expand the universe of p53 target genes. 161
A selective p53 activator and anticancer agent to improve colorectal cancer therapy 161
JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress. 160
The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma 160
Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics. 160
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes. 159
SMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy 159
Mutagenicity of N3-methyladenine: a multi-translesion polymerase affair. 158
Nutlin-Induced Apoptosis Is Specified by a Translation Program Regulated by PCBP2 and DHX30 158
Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation. 157
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 156
Structure of p73 DNA-binding domain tetramer modulates p73 transactivation. 156
A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network 156
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma 156
Functional analysis of CDKN2A 5'UTR variants associated with family history of melanoma 154
Comparison of the biological effects of MMS and Me-lex, a minor groove methylating agent: Clarifying the role of N3-methyladenine. 153
TP53 Mutants in the Tower of Babel of Cancer Progression. 151
Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule 150
High frequency of genomic deletions induced by Me-lex, a sequence selective N3-adenine methylating agent, at the Hprt locus in Chinese hamster ovary cells. 149
Identification of new p53 target microRNAs by bioinformatics and functional analysis 148
Α-mangostin and gambogic acid as potential inhibitors of the p53-MDM2 interaction revealed by a yeast approach. 144
LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis 142
Influences of base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence-selective N3-adenine methylating agent 142
P63 modulates the expression of the WDFY2 gene which is implicated in cancer regulation and limb development 140
The expanding universe of p53 targets 137
Transcriptional properties of feline p53 and its tumour-associated mutants: a yeast-based approach. 137
More targets, more pathways and more clues for mutant p53. 132
DHX30 coordinates cytoplasmic translation and mitochondrial function contributing to cancer cell survival 131
Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction. 130
The structure formed by inverted repeats in p53 response elements determines the transactivation activity of p53 protein 130
Transactivation by partial function P53 family mutants is increased by the presence of G-quadruplexes at a promoter site 129
Structural studies on mechanisms to activate mutant p53. 129
Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation 127
TranSNPs: A class of functional SNPs affecting mRNA translation potential revealed by fraction-based allelic imbalance 124
PRIMA-1 cytotoxicity correlates with nucleolar localization and degradation of mutant p53 in breast cancer cells. 122
∆N-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites. 121
Identification of a novel TP53 germline mutation in a large Italian Li-Fraumeni syndrome Family. 120
Studying RNP Composition with RIP 120
Transcriptional defect of an inherited NKX2-5 haplotype comprising a SNP, a nonsynonymous and a synonymous mutation, associated with human congenital heart disease. 119
Noncanonical DNA motifs as transactivation targets by wild type and mutant p53. 119
The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage. 119
Functional diversity in the gene network controlled by the master regulator p53 in humans. 119
Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences 118
XRCC1 deficiency influences the cytotoxicity and the genomic instability induced by Me-lex, a specific inducer of N3-methyladenine. 116
Structural Basis of Mutation-Dependent p53 Tetramerization Deficiency 114
Compartment-specific and ELAVL1-coordinated regulation of intronic polyadenylation isoforms by doxorubicin 114
Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype. 113
Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system. 113
MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma. 113
Functional evolution of the p53 regulatory network through its target response elements 110
Enhanced cytotoxicity of prenylated chalcone against tumour cells via disruption of the p53-MDM2 interaction 108
Tumour p53 mutations exhibit promoter selective dominance over wild type p53 108
PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells. 107
Transcriptional functionality of germ line p53 mutants influences cancer phenotype 103
The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes. 102
Regulation of human PTCH1b expression by different 5' untranslated region cis-regulatory elements 102
The influence of quadruplex structure in proximity to P53 target sequences on the transactivation potential of p53 alpha isoforms 100
Totale 16.503
Categoria #
all - tutte 69.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.105
Totale 70.557


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021579 0 0 0 0 0 0 0 0 0 177 174 228
2021/20221.340 67 190 18 53 53 40 60 230 108 100 140 281
2022/20231.873 311 247 45 281 165 271 9 116 223 18 109 78
2023/2024672 39 65 44 29 67 210 53 47 7 23 14 74
2024/20252.704 25 18 159 529 173 330 163 209 280 461 176 181
2025/20265.119 393 157 733 693 628 368 1.145 180 455 367 0 0
Totale 17.591